CRANE STRATEGIES

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biopharmaceutical development and manufacturing

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $50,000.00 income · posted Jan 21, 2026

Lobbying activity 1

Budget/Appropriations

Biodefense funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem